Clinical Characteristics of Long-Term Survivors With Nivolumab in Pretreated Advanced NSCLC from Real-World Data (RWD)

被引:0
|
作者
Garcia, M. [1 ]
Calles, A. [1 ]
Lobo, M. [1 ]
Alvarez Alvarez, R. [1 ]
机构
[1] Hosp Gregorio Maranon, Med Oncol, Madrid, Spain
关键词
advanced non-small cell lung cancer; nivolumab; immunotherapy;
D O I
10.1016/j.jtho.2018.08.935
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P1.15-03
引用
收藏
页码:S612 / S612
页数:1
相关论文
共 50 条
  • [1] Clinical Characteristics of Long-Term Survivors with Nivolumab in Previously Treated Advanced NSCLC from Real World Data
    Watanabe, Y.
    Mizutani, H.
    Kato, Y.
    Yamane, Y.
    Kurimoto, F.
    Sakai, H.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S723 - S723
  • [2] Thyroid Disfunction in Advanced NSCLC Patients Treated with Nivolumab out of Clinical Trial: A Real-World Data Analysis
    Palmero, R.
    Ruffinelli, J. C.
    Alanya, E.
    Marin, J. A.
    Ferrer, M.
    Jove, M.
    Mesia, C.
    Arellano, M.
    Brao, I.
    Cardenal, F.
    Peiro, I.
    Nadal, E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2432 - S2432
  • [3] Genomic landscape in advanced gastric cancer from real-world data (RWD) of clinical genomic testing
    Yamamoto, H.
    Oikawa, R.
    Takeda, H.
    Umemoto, K.
    Doi, A.
    Horie, Y.
    Ogura, T.
    Mizukami, T.
    Izawa, N.
    Moore, J. A.
    Sokol, E.
    Sunakawa, Y.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1066 - S1067
  • [5] Real-world long-term outcomes of advanced/metastatic NSCLC patients treated with EGFR TKIs in Nottinghamshire
    Lopez-Escola, C.
    Mengoli, K.
    Sheikh, O.
    Karim, S.
    Sadiq, M.
    [J]. LUNG CANCER, 2020, 139 : S62 - S62
  • [6] EXPERIENCE IN IMPLEMENTING CLINICAL TRIAL TO REAL-WORLD DATA (RWD) LINKAGE
    NajafZadeh, M.
    Saunders, D.
    Demirci, S.
    Niamathullah, S.
    Vaccaro, T.
    McConnochie, B.
    Polewaczyk, J.
    Tyagi, A.
    Ahmed, A.
    Oromendia, A.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S393 - S393
  • [7] Long-term persistence with mirabegron in a real-world clinical setting
    Wada, Naoki
    Watanabe, Masaki
    Banjo, Hiroko
    Tsuchida, Miyu
    Hori, Junichi
    Tamaki, Gaku
    Azumi, Makoto
    Kita, Masafumi
    Kakizaki, Hidehiro
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (05) : 501 - 506
  • [8] Long-term neuroprotective effects of natalizumab and fingolimod in multiple sclerosis: Evidence from real-world clinical data
    Noteboom, S.
    Strijbis, E. M. M.
    Coerver, E. M. E.
    Colato, E.
    van Kempen, Z. L. E.
    Jasperse, B.
    Vrenken, H.
    Killestein, J.
    Schoonheim, M. M.
    Steenwijk, M. D.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 87
  • [10] Genomic landscape in small intestine cancer from real-world data (RWD) of clinical genomic testing
    Takeda, Hiroyuki
    Yamamoto, Hiroyuki
    Oikawa, Ritsuko
    Umemoto, Kumiko
    Doi, Ayako
    Horie, Yoshiki
    Mizukami, Takuro
    Ogura, Takashi
    Izawa, Naoki
    Moore, Jay A.
    Sokol, Ethan
    Sunakawa, Yu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)